AU Patent

AU2012205240B2 — Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines

Assigned to Boehringer Ingelheim International GmbH · Expires 2015-03-26 · 11y expired

What this patent protects

C:\NRPortbl\UCC\REC\4479582_1 DOC-19/07/2012 Abstract The invention relates to an improved method for producing enantiomer-free 8-(3 amino-piperidin-1 -yl)-xanthenes.

USPTO Abstract

C:\NRPortbl\UCC\REC\4479582_1 DOC-19/07/2012 Abstract The invention relates to an improved method for producing enantiomer-free 8-(3 amino-piperidin-1 -yl)-xanthenes.

Drugs covered by this patent

Patent Metadata

Patent number
AU2012205240B2
Jurisdiction
AU
Classification
—
Expires
2015-03-26
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.